Natalie Livingston, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymph Nodes | 1 | 2024 | 3483 | 0.410 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2024 | 4515 | 0.390 |
Why?
|
| Nanoparticles | 3 | 2023 | 1923 | 0.280 |
Why?
|
| Antigen-Presenting Cells | 4 | 2023 | 944 | 0.260 |
Why?
|
| Immunotherapy | 6 | 2024 | 4611 | 0.210 |
Why?
|
| Artificial Cells | 1 | 2021 | 16 | 0.190 |
Why?
|
| Hydrogels | 1 | 2024 | 723 | 0.150 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2023 | 971 | 0.150 |
Why?
|
| Interleukin-2 | 1 | 2024 | 1871 | 0.140 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 1720 | 0.130 |
Why?
|
| Lymphocyte Activation | 2 | 2024 | 5418 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 21793 | 0.130 |
Why?
|
| Polymers | 1 | 2021 | 1613 | 0.110 |
Why?
|
| Melanoma | 2 | 2023 | 5658 | 0.110 |
Why?
|
| Vaccines | 1 | 2021 | 833 | 0.110 |
Why?
|
| Dendritic Cells | 1 | 2023 | 2719 | 0.100 |
Why?
|
| Biocompatible Materials | 1 | 2020 | 1686 | 0.100 |
Why?
|
| Peptides | 1 | 2024 | 4316 | 0.100 |
Why?
|
| Influenza, Human | 1 | 2022 | 1531 | 0.090 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 16795 | 0.070 |
Why?
|
| Antigens | 2 | 2023 | 1442 | 0.070 |
Why?
|
| Mice | 4 | 2024 | 80750 | 0.060 |
Why?
|
| Cations | 1 | 2021 | 238 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2023 | 562 | 0.040 |
Why?
|
| Liposomes | 1 | 2023 | 774 | 0.040 |
Why?
|
| Animals | 4 | 2024 | 167153 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 2022 | 979 | 0.040 |
Why?
|
| Surface Properties | 1 | 2021 | 1155 | 0.040 |
Why?
|
| Particle Size | 1 | 2021 | 1636 | 0.030 |
Why?
|
| Cancer Vaccines | 1 | 2023 | 1050 | 0.030 |
Why?
|
| Epitopes | 1 | 2022 | 2501 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2023 | 2001 | 0.030 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 10057 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 2520 | 0.030 |
Why?
|
| Lipids | 1 | 2023 | 3333 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2021 | 1577 | 0.030 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2021 | 1427 | 0.030 |
Why?
|
| Neoplasms | 1 | 2020 | 21887 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2023 | 12753 | 0.020 |
Why?
|
| Cytokines | 1 | 2022 | 7263 | 0.020 |
Why?
|
| Humans | 4 | 2024 | 755562 | 0.020 |
Why?
|
| Female | 1 | 2023 | 387930 | 0.000 |
Why?
|